Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabis extract for chronic muscular temporomandibular disorder pain
RBR-5996nhjPhase 2Not yet recruiting
- Sponsor
- Universidade Estadual Paulista
- Start
- Jan 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in temporomandibular disorder (TMD) comparing Full-spectrum cannabis extract with Placebo (2 arms). Planned start Jan 2024; status: not yet recruiting.
02
Drugs
VER-01
03
Conditions
temporomandibular disorder (TMD)
Beyond the preview
Go deeper on RBR-5996nhj.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-5996nhj.